Home › Funds › Crossingbridge Advisors, LLC › IPCX
Crossingbridge Advisors, LLC position in IPCX
ROIVANT SCIENCES LTD
Crossingbridge Advisors, LLC reported holding 1,235,944 shares of IPCX (ROIVANT SCIENCES LTD) in its Q2 2026 13F filing — a position valued at US$12.8M, representing 2.40% of its reported portfolio and ranking #4 among its reported holdings. Crossingbridge Advisors, LLC has disclosed IPCX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Crossingbridge Advisors, LLC's IPCX position evolved
Crossingbridge Advisors, LLC first disclosed a stake in IPCX in Q4 2025 at 649,756 shares (US$6.6M). The position peaked in Q1 2026 at 1,236,344 shares, worth US$12.9M. Across 3 filings, Crossingbridge Advisors, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,235,944 shares valued at US$12.8M. Notable position changes include a 90% increase in Q1 2026.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 649.76K | $6.59M | New |
| Q1 2026 | 1.24M | $12.86M | Add |
| Q2 2026 | 1.24M | $12.77M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IPCX and 13F data
IPCX (ROIVANT SCIENCES LTD) is a company whose sector is not yet classified in our data. 60 other funds we track also report a position in IPCX — the largest reported positions include BERKLEY W R CORP (US$22.8M), LINDEN ADVISORS LP (US$19.2M), RLH Capital LLC (US$14.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IPCX
- BERKLEY W R CORP 2.21M sh · $22.82M · Q2 2026
- LINDEN ADVISORS LP 1.86M sh · $19.25M · Q2 2026
- RLH Capital LLC 1.42M sh · $14.72M · Q2 2026
- MMCAP International Inc. SPC 1.40M sh · $14.46M · Q2 2026
- RiverPark Advisors, LLC 960.94K sh · $9.92M · Q2 2026
- Quarry LP 907.56K sh · $9.38M · Q2 2026
- Mercuria Capital Strategies, LLC 535.00K sh · $5.53M · Q2 2026
- Wealthspring Capital LLC 511.52K sh · $5.28M · Q2 2026
- Mint Tower Capital Management B.V. 450.00K sh · $4.65M · Q2 2026
- SkyView Investment Advisors, LLC 153.31K sh · $1.58M · Q2 2026
More on Crossingbridge Advisors, LLC
FAQ
How long has Crossingbridge Advisors, LLC held IPCX?
Crossingbridge Advisors, LLC has disclosed IPCX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Crossingbridge Advisors, LLC's current position in IPCX?
As of Q2 2026, Crossingbridge Advisors, LLC holds 1.24M shares of IPCX (ROIVANT SCIENCES LTD), valued at $12.77M, representing 2.40% of its reported portfolio and ranking #4.
Has Crossingbridge Advisors, LLC been buying or selling IPCX?
In the latest 13F filing (Q2 2026), Crossingbridge Advisors, LLC held unchanged its position in IPCX. The position peaked in Q1 2026 at 1.24M shares.
Which other funds hold IPCX?
Other major institutional holders of IPCX include BERKLEY W R CORP, LINDEN ADVISORS LP, RLH Capital LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.